Novo Integrated Sciences (NASDAQ:NVOS) Trading Down 8.1%

Novo Integrated Sciences, Inc. (NASDAQ:NVOSGet Free Report)’s share price was down 8.1% on Thursday . The company traded as low as $1.55 and last traded at $1.59. Approximately 910,124 shares changed hands during trading, a decline of 70% from the average daily volume of 3,066,566 shares. The stock had previously closed at $1.73.

Novo Integrated Sciences Stock Performance

The stock has a 50-day moving average price of $0.52 and a two-hundred day moving average price of $0.27. The stock has a market capitalization of $26.73 million, a P/E ratio of -0.17 and a beta of -1.30.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC increased its stake in Novo Integrated Sciences by 2,942.0% in the 2nd quarter. Geode Capital Management LLC now owns 816,601 shares of the company’s stock worth $121,000 after buying an additional 789,757 shares in the last quarter. BlackRock Inc. grew its holdings in Novo Integrated Sciences by 114.5% during the 1st quarter. BlackRock Inc. now owns 23,682 shares of the company’s stock valued at $54,000 after buying an additional 12,644 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Novo Integrated Sciences during the fourth quarter valued at approximately $44,000. State Street Corp lifted its holdings in shares of Novo Integrated Sciences by 1,282.4% in the second quarter. State Street Corp now owns 290,192 shares of the company’s stock worth $43,000 after buying an additional 269,200 shares in the last quarter. Finally, Millennium Management LLC bought a new position in shares of Novo Integrated Sciences during the fourth quarter worth $25,000. Institutional investors own 1.48% of the company’s stock.

About Novo Integrated Sciences

(Get Free Report)

Novo Integrated Sciences, Inc, together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.

Further Reading

Receive News & Ratings for Novo Integrated Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Integrated Sciences and related companies with MarketBeat.com's FREE daily email newsletter.